Recently, the American College of Allergy, Asthma and Immunology (ACAAI) took part in publishing a practice guideline for allergists and other healthcare workers about the latest developments in understanding allergic rhinitis.

The first comprehensive, prospective study of smoking habits in patients with non-small cell lung cancer (NSCLC) who were enrolled in a phase III early-stage trial revealed that there was a high rate of smoking reduction and cessation following study entry, according to research published today in the Journal of Thoracic Oncology. The JTO is the official journal of the International Association for the Study of Lung Cancer.

A new survey in Annals of Allergy, Asthma and Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology, shows that of those who used cannabis, about half smoked it while a third vaped – both “inhalation routes” likely to affect one’s lungs.

Following the European Union’s announcements of its ambitious Beating Cancer Plan, respiratory doctors, represented by the European Respiratory Society (ERS), call on the European Commission, EU policymakers and national governments to set a goal to increase early diagnosis of lung cancer in Europe by 20% by 2030.

Some COVID-19 patients experience long-lasting skin symptoms that vary according to type of COVID-19 skin rash, a late-breaking abstract will reveal today at the 29th EADV Virtual Congress.

A new study points to a need for oncologists to ask their patients about sexual health after chemotherapy, radiation and other cancer treatments. In a survey of nearly 400 cancer survivors, 87% said they experienced sexual side effects, but most also said their oncologist had not formally asked about them.

Asthma and food hypersensitivity at age 12 is associated with an increased risk of having irritable bowel syndrome at 16, a new study presented today at UEG Week Virtual 2020 has found

Top five studies on primary liver cancer presented during the EASL Digital International Liver Congress ILC202o

New research presented at the Annual Meeting of the European Association for the Study of Diabetes shows that the drug dapagliflozin, originally developed to treat type 2 diabetes, reduces the risk of declining kidney function, kidney failure, heart failure and death in patients with chronic kidney disease, whether or not they have type 2 diabetes

High-intensity interval training combining rowing and cycling improves insulin sensitivity, body composition and cardiorespiratory fitness in obesity and type 2 diabetes